Literature DB >> 17160430

Incidence of Crohn's disease and CARD15 mutation in a small township in Sicily.

M Cottone1, M C Renda, A Mattaliano, L Oliva, W Fries, V Criscuoli, I Modesto, D Scimeca, A Maggio, A Casà, S Maisano, F Mocciaro, A Sferrazza, A Orlando.   

Abstract

BACKGROUND: The incidence of Crohn's disease (CD) has been shown to be lower in Southern than in Northern Europe. Data on the frequency of the NOD2/CARD15 mutations for Mediterranean area are very scant. AIM: To determine the incidence of CD from 1979 to 2002 in a township in Sicily together with the allele frequency of NOD2/CARD15 mutations in patients, family members and controls, and to determine the allele frequency of these mutations in sporadic CD from other areas of Sicily in comparison with a control population.
METHODS: Casteltermini is a small town close to Agrigento (Sicily) with a population of 9,130 inhabitants. All the diagnoses of inflammatory bowel disease (IBD) made from 1979 to 2002 were obtained through the local health authority. NOD2/CARD15 mutations were studied in 23 out of the 29 patients with CD in Casteltermini, in 60 family members and in 64 controls. NOD2/CARD15 was also studied in 80 sporadic cases of CD disease among Sicilians outside Casteltermini and 118 healthy controls.
RESULTS: From 1979 to 2002, 29 patients with CD and 13 patients with ulcerative colitis (UC) were registered. The 6-year mean incidence of CD ranged from 8.0 to 17 new cases for every 100,000 inhabitants, whereas the mean incidence of UC ranged from five new cases to 7.8 for every 100,000 inhabitants. The allele frequencies of NOD2/CARD15 mutations (L1007finsC, G908R, R702W) were 8.7, 4.3 and 8.7%, respectively, in CD cases; 5.0, 4.2 and 3.1% in family members; 1.6, 2.3 and 3.1% in controls. In sporadic Sicilian CD patients outside Casteltermini the allele frequency was 7.5, 8.1, 6.2% whereas in control population it was 3.3, 1.6, 1.6%.
CONCLUSIONS: A high incidence of CD compared with UC was observed in this small town in Southern Italy. The frequency of NOD2/CARD15 mutations in CD is similar to other Caucasian population studied so far.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17160430     DOI: 10.1007/s10654-006-9054-5

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  17 in total

1.  Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB.

Authors:  Y Ogura; N Inohara; A Benito; F F Chen; S Yamaoka; G Nunez
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

2.  NOD2 insertion mutation in a Cretan Crohn's disease population.

Authors:  Maria Roussomoustakaki; Ioannis Koutroubakis; Em Manouel Vardas; Philippos Dimoulios; Elias A Kouroumalis; Stavroula Baritaki; George Koutsoudakis; Elias Krambovitis
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

3.  Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy.

Authors:  Walter Fries; Maria C Renda; Maria A Lo Presti; Antonella Raso; Ambrogio Orlando; Lorenzo Oliva; Maria R Giofré; Aurelio Maggio; Anna Mattaliano; Alfredo Macaluso; Mario Cottone
Journal:  Am J Gastroenterol       Date:  2005-12       Impact factor: 10.864

4.  Familial aggregation of inflammatory bowel disease in a Mediterranean area.

Authors:  C Cipolla; A Magliocco; L Oliva; M Cottone
Journal:  Eur J Epidemiol       Date:  1996-04       Impact factor: 8.082

5.  Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).

Authors:  S Shivananda; J Lennard-Jones; R Logan; N Fear; A Price; L Carpenter; M van Blankenstein
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

6.  Cluster of inflammatory bowel disease in three close college friends?

Authors:  J Aisenberg; H D Janowitz
Journal:  J Clin Gastroenterol       Date:  1993-07       Impact factor: 3.062

7.  Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis.

Authors:  Michael Economou; Thomas A Trikalinos; Konstantinos T Loizou; Epameinondas V Tsianos; John P A Ioannidis
Journal:  Am J Gastroenterol       Date:  2004-12       Impact factor: 10.864

Review 8.  Crohn's disease: the cold chain hypothesis.

Authors:  Jean-Pierre Hugot; Corinne Alberti; Dominique Berrebi; Edouard Bingen; Jean-Pierre Cézard
Journal:  Lancet       Date:  2003-12-13       Impact factor: 79.321

9.  Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study.

Authors:  V Annese; O Palmieri; A Latiano; S Ardizzone; F Castiglione; M Cottone; R D'Incà; P Gionchetti; C Papi; G Riegler; M Vecchi; A Andriulli
Journal:  Dig Liver Dis       Date:  2004-02       Impact factor: 4.088

10.  Prevalence of mutations of the NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn disease.

Authors:  J L Mendoza; L S Murillo; L Fernández; A S Peña; R Lana; E Urcelay; D M Cruz-Santamaría; E G de la Concha; M Díaz-Rubio; J García-Paredes
Journal:  Scand J Gastroenterol       Date:  2003-12       Impact factor: 2.423

View more
  8 in total

1.  Recent trends in publications in the European Journal of Epidemiology.

Authors:  Albert Hofman
Journal:  Eur J Epidemiol       Date:  2008       Impact factor: 8.082

2.  Is the time right for translation research in genomics?

Authors:  A Cecile J W Janssens
Journal:  Eur J Epidemiol       Date:  2008       Impact factor: 8.082

3.  Population-based incidence and prevalence of inflammatory bowel diseases in Milan (Northern Italy), and estimates for Italy.

Authors:  Emanuele Crocetti; Walter Bergamaschi; Antonio Giampiero Russo
Journal:  Eur J Gastroenterol Hepatol       Date:  2021-12-01       Impact factor: 2.586

4.  Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease.

Authors:  Luciana Rigoli; Claudio Romano; Rosario Alberto Caruso; Maria A Lo Presti; Chiara Di Bella; Vincenzo Procopio; Giuseppina Lo Giudice; Maria Amorini; Giuseppe Costantino; Maria D Sergi; Caterina Cuppari; Giovanna Elisa Calabro; Romina Gallizzi; Carmelo Damiano Salpietro; Walter Fries
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

5.  Autoimmunity in Rheumatic Diseases Is Induced by Microbial Infections via Crossreactivity or Molecular Mimicry.

Authors:  Taha Rashid; Alan Ebringer
Journal:  Autoimmune Dis       Date:  2012-02-20

6.  Incidence and prevalence of inflammatory bowel disease in Mexico from a nationwide cohort study in a period of 15 years (2000-2017).

Authors:  Jesús K Yamamoto-Furusho; Andrea Sarmiento-Aguilar; Joel J Toledo-Mauriño; Katya E Bozada-Gutiérrez; Francisco J Bosques-Padilla; Manuel A Martínez-Vázquez; Virgilio Marroquín-Jiménez; Rosalva García-Figueroa; Christian Jaramillo-Buendía; Rosa M Miranda-Cordero; Jesús A Valenzuela-Pérez; Yolanda Cortes-Aguilar; Janett S Jacobo-Karam; Emilio F Bermudez-Villegas
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

7.  Trend and Geographic Variation in Incidence and Prevalence of Inflammatory Bowel Disease in Regions Across China: A Nationwide Employee Study Between 2013 and 2016.

Authors:  Hong Yang; Runing Zhou; Xiaoyin Bai; Mingyue Guo; Gechong Ruan; Li Wang; Jiaming Qian
Journal:  Front Med (Lausanne)       Date:  2022-07-25

8.  Global smoking trends in inflammatory bowel disease: A systematic review of inception cohorts.

Authors:  Tom Thomas; Joht Singh Chandan; Venice Sze Wai Li; Cheuk Yin Lai; Whitney Tang; Neeraj Bhala; Gilaad G Kaplan; Siew C Ng; Subrata Ghosh
Journal:  PLoS One       Date:  2019-09-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.